Financial News
Latest News about AZN
Recent news which mentions AZN
Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter
November 12, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
From Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report
November 12, 2021
From Benzinga
5 Stocks To Watch For November 12, 2021
November 12, 2021
From Benzinga
Earnings Scheduled For November 12, 2021
November 12, 2021
From Benzinga
This Company's Innovative Targeted Radiation Therapy Could Offer Potential Hope for Cancer Patients
November 11, 2021
From Benzinga
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
November 10, 2021
From Benzinga
AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report
November 10, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
3 Best Biotech Stocks to Buy in November
November 08, 2021
From Motley Fool
Better Buy After Earnings: Moderna or Novavax?
November 08, 2021
From Motley Fool
These Clinical Results Are Good News for AstraZeneca
November 06, 2021
From Motley Fool
Handbag wars? Chanel price hikes rally luxury goods makers in Europe
November 05, 2021
From MarketWatch
Novavax Looks Primed and Ready for a Vaccine Comeback
November 04, 2021
From InvestorPlace
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
November 03, 2021
From InvestorPlace
PhaseBio's Bentracimab Reverses Ticagrelor-Associated Antiplatelet Activity In Mid-Stage Study
November 03, 2021
From Benzinga
The 1 Thing I'll be Looking for in Novavax's Earnings Report
November 03, 2021
From Motley Fool
From Benzinga
AstraZeneca To Offload Some Drug Rights To Covis Pharma For $270M
November 01, 2021
From Benzinga
From InvestorPlace
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
November 01, 2021
From InvestorPlace
Novavax Just Caught a Big Break
October 29, 2021
From InvestorPlace
From Motley Fool
From Benzinga
NVAX Stock Soars 6% as Novavax Reaches Key Vaccine Milestone
October 27, 2021
From InvestorPlace
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial
October 26, 2021
From Benzinga
Novavax is Now a Riskier Play, but Still One to Keep Your Eye On
October 25, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.